ARIH1 activates STING-mediated T-cell activation and sensitizes tumors to immune checkpoint blockade.

MLA

Liu, Xiaolan, et al. “ARIH1 Activates STING-Mediated T-Cell Activation and Sensitizes Tumors to Immune Checkpoint Blockade.” Nature Communications, vol. 14, no. 1, July 2023, p. 4066. EBSCOhost, https://doi.org/10.1038/s41467-023-39920-5.

APA

Liu, X., Cen, X., Wu, R., Chen, Z., Xie, Y., Wang, F., Shan, B., Zeng, L., Zhou, J., Xie, B., Cai, Y., Huang, J., Liang, Y., Wu, Y., Zhang, C., Wang, D., & Xia, H. (2023). ARIH1 activates STING-mediated T-cell activation and sensitizes tumors to immune checkpoint blockade. Nature Communications, 14(1), 4066. https://doi.org/10.1038/s41467-023-39920-5

Chicago

Liu, Xiaolan, Xufeng Cen, Ronghai Wu, Ziyan Chen, Yanqi Xie, Fengqi Wang, Bing Shan, et al. 2023. “ARIH1 Activates STING-Mediated T-Cell Activation and Sensitizes Tumors to Immune Checkpoint Blockade.” Nature Communications 14 (1): 4066. doi:10.1038/s41467-023-39920-5.